Paraquat is a bipyridylium compound that is used widely throughout the world as a herbicide. In most species of animals so far examined, the predominant lesion after even a single dose of paraquat was initial hyperemia of the lungs followed by respiratory insufficiency due to pulmonary fibrosis.
In the present investigation rats were given a dose of paraquat intraperitoneally once a week for 7 to 8 weeks. We also investigated the effect of prednisolone and elastase on paraquat-induced pulmonary fibrosis. We classified rats into five groups, i.e. the normal control group which was given no drug, the control group which was given paraquat alone, the elastase group which was given paraquat and elastase, the prednisolone and elastase group which was given paraquat, and the prednisolone and elastase and prednisolone group which was given paraquat and prednisolone.
1) The survival rate of the control group, the prednisolone group, the prednisolone and elastase group and the elastase group were 51.4%, 70.0%, 50.0% and 48.6%, respectively.
2) Five of 18 rats in the control group and 2 of 14 rats in the prednisolone group showed advanced pathological findings (++), while 17 rats in the elastase group and 5 rats in the prednisolone and elastase group did not show (++) pathological findings.
3) In rats which survived for 7 to 8 weeks, pathological examinations of lungs revealed a diffuse thickening of alveolar septa and a collapse of alveoli suggesting future pulmonary fibrosis.
4) There were no significant differences in body weight between the normal control group and other groups. On the other hand lung wet weights of the four groups which were given paraquat were about 2.4 times heavier than those of the normal control group.
5) Hydroxyproline contents of lung tissue in the 4 paraquat groups showed significant higher values compared with the normal control group. But there were no significant differences among these 4 groups.
6) Serum lipoperoxide values did not show any significant differences among the normal control group and the other 4 groups.
7) Plasma 6-keto PGF
1α and thromboxane B
2 values did not show any significant differences among the normal control group and the other 4 groups.
8) The plasma serotonin level of the prednisolone group was significantly lower than those in the other groups including the normal control group.
9) Plasma histamine level did not show any significant differences among the 5 groups.
The above results suggest that elastase and prednislolne might be useful drugs for patients with pulmonary fibrosis.
抄録全体を表示